Noronha O P
Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Parel, Bombay, India.
Int J Rad Appl Instrum A. 1986;37(11):1150-4. doi: 10.1016/0883-2889(86)90142-5.
The methodology adopted for the in-house preparation of seven types of "kits" used in the formulation of 99mTc-radiopharmaceuticals, viz. reticuloendothelial, hepatobiliary, renal, skeletal and blood-pool agents, and their control is described. The quality control was performed primarily by following pharmacokinetic patterns (both early vascular "dynamic" and late "static" phases) of the respective radiopharmaceuticals in Wistar strain rats subsequent to i.v. administration of the radiopharmaceuticals. The results obtained could be utilized for quality assurance of 99mTc-radiopharmaceuticals; especially those prepared in-house (from "kits") and use in diagnostic nuclear medicine. The in-house preparation of these "kits" in hospital radiopharmacy laboratories possessing adequate manufacturing facilities, skills and expertise could result in considerable savings in costs (of kits).
描述了用于制备99mTc放射性药物的七种“试剂盒”的内部制备方法,即用于网状内皮、肝胆、肾脏、骨骼和血池显像剂的试剂盒及其对照。质量控制主要通过在静脉注射放射性药物后,跟踪Wistar品系大鼠体内相应放射性药物的药代动力学模式(早期血管“动态”和晚期“静态”阶段)来进行。所获得的结果可用于99mTc放射性药物的质量保证;特别是那些内部制备(来自“试剂盒”)并用于诊断核医学的药物。在具备足够生产设施、技能和专业知识的医院放射性药物实验室内部制备这些“试剂盒”,可大幅节省(试剂盒的)成本。